Your browser doesn't support javascript.
loading
GM1 structural requirements to mediate neuronal functions.
Fazzari, Maria; Lunghi, Giulia; Di Biase, Erika; Maggioni, Margherita; Carsana, Emma Veronica; Cioccarelli, Laura; Vigani, Laura; Loberto, Nicoletta; Aureli, Massimo; Mauri, Laura; Ciampa, Maria Grazia; Valsecchi, Manuela; Takato, Koichi; Imamura, Akihiro; Ishida, Hideharu; Ben Mariem, Omar; Saporiti, Simona; Palazzolo, Luca; Chiricozzi, Elena; Eberini, Ivano; Sonnino, Sandro.
Affiliation
  • Fazzari M; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Lunghi G; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Di Biase E; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Maggioni M; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Carsana EV; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Cioccarelli L; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Vigani L; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Loberto N; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Aureli M; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Mauri L; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Ciampa MG; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Valsecchi M; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy.
  • Takato K; Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
  • Imamura A; Department of Applied Bioorganic Chemistry, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
  • Ishida H; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
  • Ben Mariem O; Department of Applied Bioorganic Chemistry, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
  • Saporiti S; Institute for Glyco-core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
  • Palazzolo L; Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", Università degli Studi di Milano, Milano, Italy.
  • Chiricozzi E; Analytical Excellence & Program Management, Merck Serono S.p.A, Rome, Italy.
  • Eberini I; Dipartimento di Scienze Farmacologiche e Biomolecolari "Rodolfo Paoletti", Università degli Studi di Milano, Milano, Italy.
  • Sonnino S; Department of Medical Biotechnology and Translational Medicine, University of Milano, Segrate, Milano, Italy. elena.chiricozzi@unimi.it.
Glycoconj J ; 40(6): 655-668, 2023 12.
Article in En | MEDLINE | ID: mdl-38100017
ABSTRACT
Since the 1980s, it has been known that the administration of ganglioside GM1 to cultured cells induced or enhanced neuronal differentiation. GM1 mechanism of action relies on its direct interaction and subsequent activation of the membrane tyrosine kinase receptor, TrkA, which naturally serves as NGF receptor. This process is mediated by the sole oligosaccharide portion of GM1, the pentasaccharide ß-Gal-(1-3)-ß-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-ß-Gal-(1-4)-ß-Glc. Here we detailed the minimum structural requirements of the oligosaccharide portion of GM1 for mediating the TrkA dependent neuritogenic processing. By in vitro and in silico biochemical approaches, we demonstrated that the minimal portion of GM1 required for the TrkA activation is the inner core of the ganglioside's oligosaccharide ß-Gal-(1-3)-ß-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-ß-Gal. The addition of a sialic acid residue at position 3 of the outer galactose of the GM1 oligosaccharide, which forms the oligosaccharide of GD1a, prevented the interaction with TrkA and the resulting neuritogenesis. On the contrary, the addition of a fucose residue at position 2 of the outer galactose, forming the Fucosyl-GM1 oligosaccharide, did not prevent the TrkA-mediated neuritogenesis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M1) Ganglioside / Galactose Language: En Journal: Glycoconj J Journal subject: BIOQUIMICA / METABOLISMO Year: 2023 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M1) Ganglioside / Galactose Language: En Journal: Glycoconj J Journal subject: BIOQUIMICA / METABOLISMO Year: 2023 Type: Article Affiliation country: Italy